Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18597734 | Non-Toxic Pest Control Compositions and Methods and Uses Thereof | March 2024 | February 2025 | Allow | 12 | 1 | 0 | Yes | No |
| 18568959 | A METHOD OF CELL LYSIS | December 2023 | May 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18387563 | BIOLOGICAL-SPECIMEN TRANSPARENTIZING AGENT, SYSTEM, AND USE THEREFOR | November 2023 | March 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18460092 | Papermaking Additive Compositions and Methods and Uses Thereof | September 2023 | December 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18460129 | Non-Toxic Plant Agent Compositions and Methods and Uses Thereof | September 2023 | March 2025 | Allow | 18 | 1 | 0 | Yes | No |
| 18460056 | Liquid Bio-Catalytic Composition | September 2023 | March 2025 | Allow | 18 | 1 | 0 | Yes | No |
| 18219581 | SYNBIOTIC COMPOSITION FOR IMPROVING IMMUNE RESPONSE AND ANTIOXIDANT CAPACITY DURING AGING AND A PROCESS FOR THE PREPARATION THEREOF | July 2023 | November 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 18213528 | Compositions and Methods for Cleaning Contaminated Solids and Liquids | June 2023 | August 2024 | Allow | 13 | 1 | 0 | No | No |
| 18329769 | Lipid Abnormalities and Association with Atopic Allergic Diseases | June 2023 | June 2025 | Abandon | 24 | 1 | 1 | No | No |
| 18188038 | Targeted Protease Compositions and Uses Related Thereto | March 2023 | September 2024 | Allow | 18 | 1 | 0 | No | No |
| 18107320 | METHOD FOR ADMINISTERING UMBILICAL CORD BLOOD OR PERIPHERAL BLOOD | February 2023 | June 2025 | Allow | 28 | 3 | 1 | Yes | No |
| 18075699 | DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENT | December 2022 | March 2024 | Abandon | 15 | 1 | 0 | No | No |
| 17992188 | BIOCATALYTIC MICROCAPSULES FOR CATALYZING GAS CONVERSION | November 2022 | January 2025 | Abandon | 26 | 2 | 1 | No | No |
| 18054664 | COMPOSITIONS AND METHODS FOR CONTROLLING HEAD BLIGHT DISEASE | November 2022 | June 2024 | Abandon | 19 | 1 | 1 | No | No |
| 17976076 | NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSES | October 2022 | June 2024 | Allow | 19 | 1 | 1 | Yes | No |
| 17959215 | METHOD FOR DETECTING OPIOIDS, OPIATES, CANNABINOIDS, OR BENZODIAZEPINES IN A SAMPLE WITH A B-GLUCURONIDASE ENZYME | October 2022 | March 2025 | Allow | 29 | 3 | 0 | Yes | No |
| 17823318 | PREPARING LIVE MICROBIAL SAMPLES AND MICROORGANISMS FOR SUBSEQUENT MASS SPECTROMETRIC MEASUREMENT AND EVALUATION | August 2022 | April 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 17813432 | METHOD FOR DENITRATION OF FLUE GAS | July 2022 | March 2024 | Abandon | 20 | 1 | 0 | No | No |
| 17784654 | BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS I797, METHOD FOR SEPARATION AND PURIFICATION THEREOF, AND USE THEREOF | June 2022 | June 2025 | Abandon | 37 | 2 | 1 | No | No |
| 17663485 | CONTIGUITY PARTICLE FORMATION AND METHODS OF USE | May 2022 | June 2025 | Allow | 37 | 4 | 0 | Yes | No |
| 17735595 | METHOD AND PLATFORM FOR DISRUPTING INTRACELLULAR MICROTUBULES | May 2022 | February 2024 | Abandon | 21 | 0 | 1 | No | No |
| 17292284 | NOVEL SPIRULINA PLATENSIS STRAIN | May 2022 | October 2024 | Allow | 41 | 1 | 0 | Yes | No |
| 17686414 | METHOD FOR PRODUCING A MATERIAL USING COLLAGEN FROM CULTURED ANIMAL CELLS | March 2022 | January 2025 | Abandon | 35 | 2 | 1 | No | No |
| 17626632 | KIT FOR PREDICTING OR DIAGNOSING NONALCOHOLIC FATTY LIVER DISEASE, AND METHOD FOR DIAGNOSING NONALCOHOLIC FATTY LIVER DISEASE | January 2022 | May 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17647655 | SYSTEM AND METHOD FOR METHANE BIODEGRADATION | January 2022 | September 2024 | Abandon | 32 | 3 | 1 | Yes | No |
| 17646978 | ASPERGILLUS NIGER F22 STRAIN HAVING NEMATICIDAL ACTIVITY AGAINST PLANT-PARASITIC NEMATODES, AND USE THEREOF | January 2022 | December 2023 | Abandon | 23 | 1 | 0 | No | No |
| 17526048 | METHODS FOR ISOLATING MICROBIAL CELLS FROM A BLOOD SAMPLE | November 2021 | September 2024 | Allow | 34 | 2 | 0 | No | No |
| 17611337 | COMPOSITION FOR DUST SUPPRESSION | November 2021 | January 2025 | Abandon | 38 | 2 | 1 | No | No |
| 17511033 | Mass Spectrometry Ionization Based-Assay For the Detection of Enzyme Activity and/or Presence | October 2021 | January 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17446961 | Non-Toxic Pest Control Compositions and Methods and Uses Thereof | September 2021 | December 2023 | Allow | 27 | 2 | 0 | Yes | No |
| 17404460 | METHOD AND APPARATUS FOR THE UTILIZATION OF ZERO FIBER AND OTHER SIDE STREAMS | August 2021 | February 2024 | Abandon | 30 | 0 | 1 | No | No |
| 17403314 | ELECTRON BEAM IRRADIATED OSTEOINDUCTIVE BONE IMPLANT | August 2021 | October 2023 | Allow | 26 | 2 | 0 | Yes | No |
| 17382875 | AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIA | July 2021 | September 2024 | Abandon | 38 | 1 | 1 | No | No |
| 17369390 | Method For Dissociation Of Cells | July 2021 | June 2025 | Abandon | 47 | 3 | 0 | No | No |
| 17419931 | METHOD FOR DECOMPOSING PERACETIC ACID AND METHOD FOR CULTURING MICROORGANISMS USING SAME | June 2021 | March 2024 | Allow | 33 | 1 | 1 | Yes | No |
| 17359752 | CHARACTERIZATION OF MICROORGANISMS VIA MALDI-TOF | June 2021 | September 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17302784 | METHODS OF USING COSMETIC COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES DERIVED FROM MICROBIAL MATS | May 2021 | June 2023 | Allow | 25 | 1 | 0 | Yes | No |
| 17239889 | SYNTHETIC COMPOSITION FOR PREVENTING OR TREATING CVD | April 2021 | June 2024 | Abandon | 37 | 2 | 0 | Yes | No |
| 17288315 | STRAIN OF CAUCASUS YOGHURT LACTOBACILLUS MSR101 AND USE THEREOF | April 2021 | July 2023 | Allow | 27 | 2 | 1 | Yes | No |
| 17234066 | Rapid Antimicrobial Susceptibility Testing Based on a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow Cytometry | April 2021 | September 2023 | Abandon | 29 | 1 | 0 | No | No |
| 17229644 | FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION USED FOR INCREASING EXERCISE PERFORMANCE AND AMELIORATING FATIGUE | April 2021 | June 2025 | Abandon | 50 | 4 | 0 | No | No |
| 17159731 | PROTEIN COMPOSITION AND METHODS FOR ANALYSING MICROBIOTA | January 2021 | January 2024 | Allow | 35 | 1 | 1 | Yes | No |
| 17150500 | Compositions and Methods for Cleaning Contaminated Solids and Liquids | January 2021 | March 2023 | Allow | 26 | 1 | 0 | No | No |
| 17260052 | SYNBIOTIC COMPOSITION FOR IMPROVING IMMUNE RESPONSE AND ANTIOXIDANT CAPACITY DURING AGING AND A PROCESS FOR THE PREPARATION THEREOF | January 2021 | December 2023 | Abandon | 35 | 1 | 1 | No | No |
| 17135847 | METHOD FOR ISOLATION AND HARVESTING MICROVESICLES | December 2020 | February 2025 | Abandon | 49 | 5 | 0 | No | No |
| 17132496 | CAPILLARY-BASED SYSTEM FOR ACCELERATED ANTIMICROBIAL SUSCEPTIBILITY TESTING | December 2020 | April 2025 | Allow | 52 | 3 | 1 | Yes | No |
| 17101588 | Product and Process for Mucus Viscosity Normalization | November 2020 | April 2025 | Allow | 53 | 2 | 1 | Yes | No |
| 16951870 | METHOD FOR EMPLOYING CORN PLANT MATERIAL COMPRISING COBS IN THE MANUFACTURE OF ETHANOL | November 2020 | May 2023 | Allow | 30 | 1 | 0 | Yes | No |
| 17053727 | METHODS AND TOOLS FOR DETERMINING CLONAL RELATEDNESS AND PREDICTING CLONAL TRAITS | November 2020 | April 2024 | Abandon | 41 | 0 | 1 | No | No |
| 16948830 | NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME | October 2020 | July 2024 | Abandon | 46 | 1 | 0 | No | No |
| 17034534 | BETA-LACTAMASE FORMULATIONS AND USES THEREOF | September 2020 | August 2024 | Allow | 47 | 2 | 0 | Yes | No |
| 17012828 | PATHOGENIC BACTERIA AND METHOD FOR DEGRADING ETHYLENE OXIDE | September 2020 | March 2022 | Abandon | 18 | 2 | 1 | No | No |
| 16999725 | METHOD OF MICROBIAL ENHANCED OIL RECOVERY BY CHANGING MICROBIAL MOTILITY | August 2020 | June 2021 | Allow | 10 | 1 | 1 | Yes | No |
| 16993280 | SACCHAROMYCES CEREVISIAE TCI907, COMPOSITION AND METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS | August 2020 | June 2024 | Abandon | 46 | 3 | 1 | No | No |
| 16968125 | CARDIOMYOCYTE PROLIFERATION PROMOTING AGENT AND USE THEREOF | August 2020 | March 2024 | Abandon | 43 | 0 | 1 | No | No |
| 16965760 | Method and Apparatus for Continuous Production of Sophorolipids | July 2020 | September 2024 | Abandon | 50 | 1 | 1 | No | No |
| 16954590 | PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH | June 2020 | November 2022 | Abandon | 29 | 1 | 1 | No | No |
| 16886791 | MYROIDES ODORATIMIMUS BIOCONTROL STRAIN FOR EFFICIENTLY DEGRADING AFLATOXIN AND APPLICATION THEREOF | May 2020 | December 2022 | Allow | 30 | 1 | 1 | Yes | No |
| 16768327 | ISOLATION AND PURE CULTURE OF AN ARCHAEBACTERIUM OF ORDER METHANOMASSILIICOCCALES | May 2020 | September 2022 | Allow | 28 | 1 | 1 | Yes | No |
| 16841599 | ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE | April 2020 | June 2024 | Abandon | 51 | 3 | 0 | No | No |
| 16832824 | Systems and Methods for Metabolic Assessment Utilizing 1-Methoxy-PMS Field | March 2020 | May 2025 | Abandon | 60 | 4 | 1 | No | No |
| 16826261 | HYPERTHERMOPHILIC AEROBIC FERMENTATION INOCULANT PREPARED BY USING MUNICIPAL SEWAGE SLUDGE AND ITS METHOD | March 2020 | July 2023 | Allow | 40 | 2 | 0 | No | No |
| 16822698 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY | March 2020 | January 2023 | Abandon | 34 | 0 | 1 | No | No |
| 16797172 | STRAINS OF BACILLUS FOR INHIBITING FOODBORNE PATHOGENS | February 2020 | February 2024 | Allow | 48 | 3 | 1 | Yes | No |
| 16787595 | ANTIGEN PROTECTION METHOD FOR ENABLING DELAYED SAMPLE PROCESSING | February 2020 | October 2024 | Allow | 57 | 3 | 1 | No | No |
| 16785396 | FLUID SEPARATION SYSTEM AND METHOD WHICH USES MAGNETIC PARTICLES | February 2020 | March 2025 | Allow | 60 | 3 | 1 | Yes | No |
| 16729243 | Process for Treating Contaminated Water | December 2019 | May 2023 | Allow | 41 | 1 | 1 | Yes | No |
| 16729236 | Papermaking Additive Compositions and Methods and Uses Thereof | December 2019 | May 2023 | Allow | 40 | 1 | 1 | Yes | No |
| 16729240 | Non-Toxic Plant Agent Compositions and Methods and Uses Thereof | December 2019 | May 2023 | Allow | 40 | 1 | 1 | Yes | No |
| 16713145 | ACOUSTIC ENERGY BASED CELL LYSIS AND NUCLEIC ACID FRAGMENTATION | December 2019 | March 2024 | Abandon | 51 | 3 | 0 | No | No |
| 16714023 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | December 2019 | June 2023 | Abandon | 42 | 4 | 1 | Yes | No |
| 16684560 | TISSUE SCAFFOLDS FOR ELECTRICALLY EXCITABLE CELLS | November 2019 | March 2022 | Allow | 28 | 2 | 1 | Yes | No |
| 16676163 | COMPOSITIONS THAT METABOLIZE OR SEQUESTER FREE SUGAR MONOMERS AND USES THEREOF | November 2019 | November 2023 | Abandon | 49 | 3 | 1 | No | Yes |
| 16675127 | CELL SIGNALING PATHWAY ACTIVATION BY LOCAL AC ELECTRIC FIELD | November 2019 | December 2022 | Allow | 37 | 2 | 1 | Yes | No |
| 16673775 | METHOD FOR DETECTING OPIOIDS, OPIATES, CANNABINOIDS, OR BENZODIAZEPINES IN A SAMPLE WITH A B-GLUCURONIDASE ENZYME | November 2019 | November 2022 | Abandon | 36 | 3 | 0 | No | No |
| 16655228 | DYNAMIC MIXING AND ELECTROPORATION CHAMBER AND SYSTEM | October 2019 | May 2024 | Abandon | 55 | 3 | 0 | No | No |
| 16500913 | Novel Strain Having Activity Of Reducing Advanced Glycation End Products And Use Thereof | October 2019 | June 2024 | Allow | 57 | 4 | 0 | Yes | No |
| 16493544 | Method for Simultaneous Quantification of Monoclonal Antibodies | September 2019 | April 2023 | Abandon | 43 | 1 | 1 | No | No |
| 16543279 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STEAM OR HEAT STERILIZATION PROCESS AND ITS METHOD OF USE | August 2019 | October 2023 | Allow | 50 | 3 | 1 | Yes | No |
| 16483720 | MODULATION OF GUT MICROBIOTA IN HUNTINGTON'S DISEASE AND RETT SYNDROME | August 2019 | April 2023 | Abandon | 44 | 3 | 1 | No | No |
| 16532354 | FAT PROCESSING SYSTEM | August 2019 | March 2022 | Abandon | 31 | 2 | 0 | Yes | No |
| 16514800 | COMPOSITIONS AND METHODS FOR CONTROLLING HEAD BLIGHT DISEASE | July 2019 | August 2022 | Allow | 37 | 3 | 1 | Yes | No |
| 16514602 | FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION USED FOR INCREASING EXERCISE PERFORMANCE AND AMELIORATING FATIGUE | July 2019 | May 2021 | Abandon | 22 | 1 | 0 | No | No |
| 16474717 | LYSINIBACILLUS ISOLATES AND USES THEREOF | June 2019 | January 2022 | Abandon | 31 | 1 | 1 | No | No |
| 16446583 | Non-Toxic Pest Control Compositions and Methods and Uses Thereof | June 2019 | May 2021 | Allow | 23 | 1 | 0 | No | No |
| 16471142 | METHOD AND APPARATUS FOR THE ISOLATION AND TREATMENT OF PARTICULATE TARGETS | June 2019 | April 2025 | Abandon | 60 | 4 | 1 | No | No |
| 16436416 | NOROVIRUS DEACTIVATOR AND METHOD FOR PRODUCING SAME, METHOD FOR DEACTIVATING NOROVIRUS, METHOD FOR PRODUCING LYSOZYME COMPONENT FOR NOROVIRUS DEACTIVATION USE, PROPHYLACTIC OR THERAPEUTIC AGENT FOR NOROVIRUS INFECTION, AND EXTERNAL PREPARATION FOR SKIN FOR NOROVIRUS DEACTIVATION PURPOSES | June 2019 | July 2021 | Allow | 25 | 1 | 0 | Yes | No |
| 16429287 | IDENTIFICATION OF MICROORGANISMS USING DISPOSABLE DUAL REFLECTION SUBSTRATE FOR MEASURING INFRARED SPECTRA OF SAID MICROORGANISMS | June 2019 | March 2022 | Abandon | 34 | 0 | 1 | No | No |
| 16429500 | PROCESSING BIOMASS | June 2019 | May 2021 | Abandon | 23 | 1 | 0 | No | No |
| 16465473 | STRAINS OF STREPTOMYCES SP, THAT ARE RESISTANT TO HEAVY METALS | May 2019 | October 2022 | Abandon | 40 | 3 | 0 | No | No |
| 16464288 | PREPARING LIVE MICROBIAL SAMPLES AND MICROORGANISMS FOR SUBSEQUENT MASS SPECTROMETRIC MEASUREMENT AND EVALUATION | May 2019 | August 2022 | Allow | 38 | 2 | 0 | Yes | No |
| 16461308 | METHOD FOR PREPARING D-PSICOSE USING MICROORGANISM OF GENUS KAISTIA | May 2019 | April 2022 | Allow | 35 | 2 | 1 | Yes | No |
| 16402341 | Methods for the Biomethanation of H2 and CO2 | May 2019 | January 2023 | Abandon | 45 | 3 | 1 | No | No |
| 16347091 | METHOD FOR PREPARING FERMENTABLE SUGARS FROM LIGNOCELLULOSIC BIOMASS | May 2019 | August 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16384741 | CONTIGUITY PARTICLE FORMATION AND METHODS OF USE | April 2019 | March 2022 | Allow | 35 | 3 | 1 | Yes | No |
| 16356692 | FREEZE-DRIED PROBIOTIC FOODSTUFFS | March 2019 | August 2024 | Allow | 60 | 7 | 1 | Yes | No |
| 16354810 | Bacterial Fermentation Methods and Compositions | March 2019 | January 2022 | Abandon | 34 | 1 | 1 | No | No |
| 16292400 | ORGANIC WASTE TREATMENT SYSTEM AND METHOD | March 2019 | February 2021 | Abandon | 24 | 0 | 1 | No | No |
| 16270630 | METHODS OF CLEANING | February 2019 | August 2024 | Abandon | 60 | 6 | 1 | No | Yes |
| 16322843 | LACTIC BACTERIA AND THE USE THEREOF FOR THE PREVENTIVE, INHIBITORY AND/OR REDUCTIVE TREATMENT OF THE FORMATION OF BACTERIAL BIOFILMS | February 2019 | May 2022 | Abandon | 40 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FERNANDEZ, SUSAN EMILY.
With a 45.5% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 25.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner FERNANDEZ, SUSAN EMILY works in Art Unit 1651 and has examined 720 patent applications in our dataset. With an allowance rate of 46.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.
Examiner FERNANDEZ, SUSAN EMILY's allowance rate of 46.0% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by FERNANDEZ, SUSAN EMILY receive 2.41 office actions before reaching final disposition. This places the examiner in the 82% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by FERNANDEZ, SUSAN EMILY is 39 months. This places the examiner in the 9% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +58.6% benefit to allowance rate for applications examined by FERNANDEZ, SUSAN EMILY. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 16.9% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 31.4% of cases where such amendments are filed. This entry rate is in the 38% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 94.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 67% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 78.4% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 57.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 68.0% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 4.7% of allowed cases (in the 89% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.